France· FR:65262139
FAMPRIDINE VIATRIS LP 10 mg, comprimé à libération prolongée
A fampridine product containing fampridine, registered in France by VIATRIS SANTE, on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Fampridine is registered in 15 of 19 countries.
Countries holding a registration under ATC N07XX07 (fampridine), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 8 of them publish a price we can compare per daily dose
Fampridine · ATC N07XX07
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of fampridine costs, country by country.
Normalised to the WHO defined daily dose (20 mg), the median price runs from $2.00 in France to $11.20 in Switzerland — a ×5.6 gap.
- France: $2.00 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Fampridine · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- CH Switzerland$11.20
- FR France$2.00
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- FAMPRIDINE
- Manufacturer
- VIATRIS SANTE
- Country
- France (FR)
- ATC code
- N07XX07
- ATC class
- Fampridine
- Defined daily dose
- 20 mg, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip133400930242230plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 28 comprimé(s)EUR 24.61
- cip133400930242247plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 56 comprimé(s)EUR 48.82
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
32 interactions on record for fampridine.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Fampridine · interactions on record
32 records
- 4 severe
- 28 moderate
Most severe, free to view
- BupropionN06AX12severe
- BupropionN07BA02severe
- IohexolV08AB02severe
- IopamidolV08AB04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Fampridine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaFAMPRIDIN SANDOZSandoz s.r.o., Praha
- NetherlandsFampridine Abdi 10 mg tabletten met verlengde afgifteAbdi Farma GmbH
- FinlandFampridin ZentivaZentiva, k.s.
- SpainFAMPRIDINA ACCORD 10 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFGAccord Healthcare S.L.U.
- SwedenFampridin Medical Valley 10 mg DepottablettMedical Valley Invest AB
- IcelandFampridin Medical ValleyMedical Valley Invest AB
- PolandFampridine AccordAccord Healthcare S.L.U.
- NorwayFampridine AccordAccord Healthcare S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Fampridin Neuraxpharm, Fampridin Ratiopharm
- Cyprus · Fampridine Sandoz, Fampridine Viatris
- Czechia · Fampridin Sandoz, Fampridine Abdi
- Germany · Fampridin Abdi, Fampridin Abz
- Denmark · Fampridin "neuraxpharm", Fampridin Medical Valley
- Spain · Fampridina Aurovitas, Fampridina Qualigen
- Finland · Fampridin Medical Valley, Fampridin Zentiva
- United Kingdom (Northern Ireland) · Elupria, Fampridine Abdi
- Greece · Fadisa, Fampridine Sandoz
- Croatia · Fampridin Sandoz, Fampridin Teva
- Hungary · Fampridine Rontis
- Ireland · Fampridine Rowa
- Iceland · Fampridin Medical Valley, Fampridin Neuraxpharm
- Italy · Fampridina Abdi
- Liechtenstein · Fampridine Accord, Fampyra
- Luxembourg · Fampridine Eg
- Malta · Fampridine Viatris
- Netherlands · Fampridine Abdi, Fampridine Ascend
- Norway · Fampridin Medical Valley, Fampridin Neuraxpharm
- Poland · Fampridine Sandoz, Fampridine Teva
- Portugal · Fampridina Ascend, Fampridina Generis
- Sweden · Fampridin Medical Valley, Fampridin Zentiva
- Slovenia · Fampridin Stada, Fampridin Teva
- Slovakia · Fampridín Teva, Fampridine Sandoz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1dede7aa-cd2c-4b3b-8fae-563517d14d6c GET /v1/drugs/1dede7aa-cd2c-4b3b-8fae-563517d14d6c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65262139",
"date_amm": "2021-11-19",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "FAMPRIDINE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé à libération prolongée",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about fampridine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.